C-terminal variants of the P2X7 receptor are associated with prostate cancer progression and bone metastasis - evidence from clinical and pre-clinical data.
Cancer Commun (Lond). 2022 Dec 29. doi: 10.1002/cac2.12391. Online ahead of print.
Cancer Commun (Lond). 2022.
PMID: 36582013
Free article.
No abstract available.